Table 2.
Guideline adherence to, measured as the probability of, prescription of lipid-lowering medications by year
| Year | Primary prevention | Secondary prevention | ||
|---|---|---|---|---|
| Crude (%) n = 756,943 | Adjusteda (%) n = 238,895 | Crude (%) n = 447,423 | Adjusteda (%) n = 142,739 | |
| Mean (95% CI) | Mean (95% CI) | Mean (95% CI) | Mean (95% CI) | |
| 2007 | 34.7 (34.3–35.2) | 36.2 (34.8–37.5) | 70.7 (70.2–71.2) | 58.6 (56.8–60.5) |
| 2008 | 39.0 (38.6–39.4) | 40.3 (39.0–41.6) | 72.9 (72.4–73.3) | 63.0 (61.3–64.7) |
| 2009 | 42.7 (42.4–43.1) | 43.8 (42.4–45.1) | 74.7 (74.3–75.1) | 66.2 (64.5–67.8) |
| 2010 | 44.8 (44.5–45.1) | 46.3 (44.9–47.6) | 74.7 (74.4–75.1) | 67.8 (66.2–69.4) |
| 2011 | 46.8 (46.5–47.1) | 46.6 (45.2–48.0) | 75.1 (74.8–75.4) | 69.1 (67.5–70.7) |
| 2012 | 47.4 (47.1–47.7) | 46.6 (45.2–48.0) | 73.6 (73.2–73.9) | 67.9 (66.2–69.5) |
| 2013 | 47.6 (47.3–47.9) | 46.6 (45.2–48.0) | 71.8 (71.5–72.2) | 66.8 (65.1–68.4) |
| 2014 | 48.3 (48.0–48.6) | 46.1 (44.7–47.5) | 70.9 (70.5–71.3) | 65.9 (64.2–67.5) |
aAdjusted for year, county council, type of care, sex, age, HbA1c, eGFR, diabetes duration, diabetes medications, antihypertensives, antiplatelets, blood pressure, microalbuminuria, macroalbuminuria, BMI, physical activity, smoking and cholesterol levels